Protagonist Therapeutics, Inc. <PTGX.O>: Truist Securities raises target price to $170 from $145
PTGX•Related News
Sight Sciences names Kashif Rashid chief legal officer, replacing Jeremy Hayden
SGHT•
Amass Brands schedules Q2 earnings conference call
AMSS•
Ferguson FY26 Q2 adjusted diluted EPS rises 5.3% to $3.39; net sales increase 4.6% to $8.75 billion vs FY25 Q2
FERG•
Spectrum Brands Holdings, Inc. <SPB.N>: Oppenheimer raises target price to $100 from $85
SPB•
Aluminium climbs for 6th straight session as inventory draw continues
XLB•